ImmuneWorks

IW001 is targeted to idiopathic pulmonary fibrosis (IPF) patients who have autoimmunity against collagen V (40% of all 200,000 IPF patients). IW001 m....

Get a Demo and See the Full Profile

Get a demo today to see profiles of ImmuneWorks plus 5903 other startups.

Learn More About ImmuneWorks

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation

Competing Startups

More